Terms: = Sarcomas AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Treatment
13 results:
1. Sotorasib with panitumumab in chemotherapy-refractory KRAS
Kuboki Y; Fakih M; Strickler J; Yaeger R; Masuishi T; Kim EJ; Bestvina CM; Kopetz S; Falchook GS; Langer C; Krauss J; Puri S; Cardona P; Chan E; Varrieur T; Mukundan L; Anderson A; Tran Q; Hong DS
Nat Med; 2024 Jan; 30(1):265-270. PubMed ID: 38177853
[TBL] [Abstract] [Full Text] [Related]
2. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Wang W; Zhang D; Chang D; Li Y; Ren L
Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
[TBL] [Abstract] [Full Text] [Related]
3. miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFβ, and Wnt signaling.
Mazzu YZ; Hu Y; Shen Y; Tuschl T; Singer S
Sci Rep; 2019 Mar; 9(1):3197. PubMed ID: 30824765
[TBL] [Abstract] [Full Text] [Related]
4. ING5 is a Potential Target for Osteosarcoma Therapy.
Zhang X; Xu ZH; Xie H; Sun YW; Liu J; Zhao YB
Technol Cancer Res Treat; 2018 Jan; 17():1533033818762680. PubMed ID: 29528777
[TBL] [Abstract] [Full Text] [Related]
5. Clinical impact of extensive molecular profiling in advanced cancer patients.
Cousin S; Grellety T; Toulmonde M; Auzanneau C; Khalifa E; Laizet Y; Tran K; Le Moulec S; Floquet A; Garbay D; Robert J; Hostein I; Soubeyran I; Italiano A
J Hematol Oncol; 2017 Feb; 10(1):45. PubMed ID: 28179005
[TBL] [Abstract] [Full Text] [Related]
6. The TAZ-miR-224-smad4 axis promotes tumorigenesis in osteosarcoma.
Ma J; Huang K; Ma Y; Zhou M; Fan S
Cell Death Dis; 2017 Jan; 8(1):e2539. PubMed ID: 28055015
[TBL] [Abstract] [Full Text] [Related]
7. Curcumin inhibits the proliferation and invasion of human osteosarcoma cell line MG-63 by regulating miR-138.
Yu D; An F; He X; Cao X
Int J Clin Exp Pathol; 2015; 8(11):14946-52. PubMed ID: 26823826
[TBL] [Abstract] [Full Text] [Related]
8. Using next-generation sequencing to determine potential molecularly guided therapy options for patients with resectable pancreatic adenocarcinoma.
Wright GP; Chesla DW; Chung MH
Am J Surg; 2016 Mar; 211(3):506-11. PubMed ID: 26754455
[TBL] [Abstract] [Full Text] [Related]
9. Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma.
Huang J; Löhr JM; Nilsson M; Segersvärd R; Matsson H; Verbeke C; Heuchel R; Kere J; Iafrate AJ; Zheng Z; Ye W
Clin Chem; 2015 Nov; 61(11):1408-16. PubMed ID: 26378065
[TBL] [Abstract] [Full Text] [Related]
10. Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
Fotouhi O; Adel Fahmideh M; Kjellman M; Sulaiman L; Höög A; Zedenius J; Hashemi J; Larsson C
Epigenetics; 2014 Jul; 9(7):987-97. PubMed ID: 24762809
[TBL] [Abstract] [Full Text] [Related]
11. Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features.
Zhang X; Liu X; Joseph L; Zhao L; Hart J; Xiao SY
Hum Pathol; 2014 Mar; 45(3):621-7. PubMed ID: 24457081
[TBL] [Abstract] [Full Text] [Related]
12. Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method.
Rückert F; Aust D; Böhme I; Werner K; Brandt A; Diamandis EP; Krautz C; Hering S; Saeger HD; Grützmann R; Pilarsky C
J Surg Res; 2012 Jan; 172(1):29-39. PubMed ID: 21683373
[TBL] [Abstract] [Full Text] [Related]
13. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
[TBL] [Abstract] [Full Text] [Related]
